1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
RESIDUES A 1 - A 10, A 99 - A 105, B 1 - B 2, AND B 11 - B 12 ARE DISORDERED IN SOLUTION; THEREFORE, COORDINATES DISPLAY LARGE RMSD VALUES FOR THESE ATOMS.
Pascal, S.M.
Singer, A.U.
Gish, G.
Yamazaki, T.
Shoelson, S.E.
Pawson, T.
Kay, L.E.
Forman-Kay, J.D.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C9 H12 N O6 P
261.168
n
O-PHOSPHOTYROSINE
PHOSPHONOTYROSINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Cell(Cambridge,Mass.)
CELLB5
0998
0092-8674
77
461
472
10.1016/0092-8674(94)90160-0
8181064
Nuclear magnetic resonance structure of an SH2 domain of phospholipase C-gamma 1 complexed with a high affinity binding peptide.
1994
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
12275.924
PHOSPHOLIPASE C GAMMA-1, C-TERMINAL SH2 DOMAIN
3.1.4.11
1
man
polymer
1480.532
PHOSPHOPEPTIDE FROM PDGF
1
man
polymer
no
no
GSPGIHESKEWYHASLTRAQAEHMLMRVPRDGAFLVRKRNEPNSYAISFRAEGKIKHCRVQQEGQTVMLGNSEFDSLVDL
ISYYEKHPLYRKMKLRYPINEENSS
GSPGIHESKEWYHASLTRAQAEHMLMRVPRDGAFLVRKRNEPNSYAISFRAEGKIKHCRVQQEGQTVMLGNSEFDSLVDL
ISYYEKHPLYRKMKLRYPINEENSS
A
polypeptide(L)
no
yes
DND(PTR)IIPLPDPK
DNDYIIPLPDPK
B
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
cattle
Bos
sample
9913
Bos taurus
cattle
Bos
sample
9913
Bos taurus
pdbx_database_status
pdbx_struct_assembly
pdbx_struct_oper_list
struct_conf
struct_conf_type
repository
Initial release
Version format compliance
Version format compliance
Derived calculations
Other
1
0
1995-01-26
1
1
2008-03-03
1
2
2011-07-13
1
3
2017-11-29
_pdbx_database_status.process_site
Y
BNL
1994-08-19
REL
1
BRUNGER
refinement
X-PLOR
GLY
1
n
1
GLY
1
A
SER
2
n
2
SER
2
A
PRO
3
n
3
PRO
3
A
GLY
4
n
4
GLY
4
A
ILE
5
n
5
ILE
5
A
HIS
6
n
6
HIS
6
A
GLU
7
n
7
GLU
7
A
SER
8
n
8
SER
8
A
LYS
9
n
9
LYS
9
A
GLU
10
n
10
GLU
10
A
TRP
11
n
11
TRP
11
A
TYR
12
n
12
TYR
12
A
HIS
13
n
13
HIS
13
A
ALA
14
n
14
ALA
14
A
SER
15
n
15
SER
15
A
LEU
16
n
16
LEU
16
A
THR
17
n
17
THR
17
A
ARG
18
n
18
ARG
18
A
ALA
19
n
19
ALA
19
A
GLN
20
n
20
GLN
20
A
ALA
21
n
21
ALA
21
A
GLU
22
n
22
GLU
22
A
HIS
23
n
23
HIS
23
A
MET
24
n
24
MET
24
A
LEU
25
n
25
LEU
25
A
MET
26
n
26
MET
26
A
ARG
27
n
27
ARG
27
A
VAL
28
n
28
VAL
28
A
PRO
29
n
29
PRO
29
A
ARG
30
n
30
ARG
30
A
ASP
31
n
31
ASP
31
A
GLY
32
n
32
GLY
32
A
ALA
33
n
33
ALA
33
A
PHE
34
n
34
PHE
34
A
LEU
35
n
35
LEU
35
A
VAL
36
n
36
VAL
36
A
ARG
37
n
37
ARG
37
A
LYS
38
n
38
LYS
38
A
ARG
39
n
39
ARG
39
A
ASN
40
n
40
ASN
40
A
GLU
41
n
41
GLU
41
A
PRO
42
n
42
PRO
42
A
ASN
43
n
43
ASN
43
A
SER
44
n
44
SER
44
A
TYR
45
n
45
TYR
45
A
ALA
46
n
46
ALA
46
A
ILE
47
n
47
ILE
47
A
SER
48
n
48
SER
48
A
PHE
49
n
49
PHE
49
A
ARG
50
n
50
ARG
50
A
ALA
51
n
51
ALA
51
A
GLU
52
n
52
GLU
52
A
GLY
53
n
53
GLY
53
A
LYS
54
n
54
LYS
54
A
ILE
55
n
55
ILE
55
A
LYS
56
n
56
LYS
56
A
HIS
57
n
57
HIS
57
A
CYS
58
n
58
CYS
58
A
ARG
59
n
59
ARG
59
A
VAL
60
n
60
VAL
60
A
GLN
61
n
61
GLN
61
A
GLN
62
n
62
GLN
62
A
GLU
63
n
63
GLU
63
A
GLY
64
n
64
GLY
64
A
GLN
65
n
65
GLN
65
A
THR
66
n
66
THR
66
A
VAL
67
n
67
VAL
67
A
MET
68
n
68
MET
68
A
LEU
69
n
69
LEU
69
A
GLY
70
n
70
GLY
70
A
ASN
71
n
71
ASN
71
A
SER
72
n
72
SER
72
A
GLU
73
n
73
GLU
73
A
PHE
74
n
74
PHE
74
A
ASP
75
n
75
ASP
75
A
SER
76
n
76
SER
76
A
LEU
77
n
77
LEU
77
A
VAL
78
n
78
VAL
78
A
ASP
79
n
79
ASP
79
A
LEU
80
n
80
LEU
80
A
ILE
81
n
81
ILE
81
A
SER
82
n
82
SER
82
A
TYR
83
n
83
TYR
83
A
TYR
84
n
84
TYR
84
A
GLU
85
n
85
GLU
85
A
LYS
86
n
86
LYS
86
A
HIS
87
n
87
HIS
87
A
PRO
88
n
88
PRO
88
A
LEU
89
n
89
LEU
89
A
TYR
90
n
90
TYR
90
A
ARG
91
n
91
ARG
91
A
LYS
92
n
92
LYS
92
A
MET
93
n
93
MET
93
A
LYS
94
n
94
LYS
94
A
LEU
95
n
95
LEU
95
A
ARG
96
n
96
ARG
96
A
TYR
97
n
97
TYR
97
A
PRO
98
n
98
PRO
98
A
ILE
99
n
99
ILE
99
A
ASN
100
n
100
ASN
100
A
GLU
101
n
101
GLU
101
A
GLU
102
n
102
GLU
102
A
ASN
103
n
103
ASN
103
A
SER
104
n
104
SER
104
A
SER
105
n
105
SER
105
A
ASP
1
n
1
ASP
1
B
ASN
2
n
2
ASN
2
B
ASP
3
n
3
ASP
3
B
PTR
4
n
4
PTR
4
B
ILE
5
n
5
ILE
5
B
ILE
6
n
6
ILE
6
B
PRO
7
n
7
PRO
7
B
LEU
8
n
8
LEU
8
B
PRO
9
n
9
PRO
9
B
ASP
10
n
10
ASP
10
B
PRO
11
n
11
PRO
11
B
LYS
12
n
12
LYS
12
B
author_defined_assembly
2
dimeric
B
PTR
4
O-PHOSPHOTYROSINE
B
PTR
4
TYR
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
HIS
13
A
N
HIS
13
A
O
VAL
36
A
O
VAL
36
A
N
LEU
35
A
N
LEU
35
A
O
SER
48
A
O
SER
48
A
N
ILE
47
A
N
ILE
47
A
O
CYS
58
A
O
CYS
58
A
N
GLN
61
A
N
GLN
61
A
O
MET
68
A
O
MET
68
A
O
VAL
67
A
O
VAL
67
A
N
PHE
74
A
N
PHE
74
1
A
ARG
18
0.313
SIDE CHAIN
1
A
ARG
27
0.308
SIDE CHAIN
1
A
ARG
30
0.167
SIDE CHAIN
1
A
ARG
39
0.231
SIDE CHAIN
1
A
ARG
50
0.309
SIDE CHAIN
1
A
ARG
59
0.279
SIDE CHAIN
1
A
ARG
91
0.212
SIDE CHAIN
1
A
HIS
6
-178.11
-142.09
1
A
GLU
7
49.03
-125.21
1
A
SER
8
47.61
-144.79
1
A
LYS
9
-171.89
-168.47
1
A
GLU
10
49.75
11.93
1
A
ARG
30
177.83
164.59
1
A
ALA
33
-170.20
121.55
1
A
ARG
39
-74.52
-166.10
1
A
ASN
40
-92.14
31.64
1
A
PRO
42
-77.83
24.43
1
A
SER
44
166.75
144.81
1
A
GLU
52
61.95
-118.08
1
A
THR
66
-152.40
-157.20
1
A
TYR
90
-110.25
-163.14
1
A
ARG
91
-77.67
25.23
1
A
LYS
92
-178.66
-43.22
1
A
LEU
95
-99.07
42.90
1
A
PRO
98
-77.68
-140.10
1
A
GLU
101
171.94
173.71
1
A
SER
104
-82.80
-77.70
1
B
PTR
4
176.87
137.73
1
B
ASP
10
69.12
142.89
model building
X-PLOR
refinement
X-PLOR
phasing
X-PLOR
PHOSPHOLIPASE C GAMMA-1, C-TERMINAL SH2 DOMAIN
NUCLEAR MAGNETIC RESONANCE STRUCTURE OF AN SH2 DOMAIN OF PHOSPHOLIPASE C-GAMMA1 COMPLEXED WITH A HIGH AFFINITY BINDING PEPTIDE
1
N
N
2
N
N
A
THR
17
A
THR
17
HELX_P
A
VAL
28
A
VAL
28
1
A
12
A
LEU
77
A
LEU
77
HELX_P
SL.IRR., BIFURCATED H-BONDS
A
HIS
87
A
HIS
87
1
B
11
covale
1.307
B
ASP
3
B
C
ASP
3
1_555
B
PTR
4
B
N
PTR
4
1_555
covale
1.313
B
PTR
4
B
C
PTR
4
1_555
B
ILE
5
B
N
ILE
5
1_555
PHOSPHORIC DIESTER HYDROLASE
PHOSPHORIC DIESTER HYDROLASE
PLCG1_BOVIN
UNP
1
1
P08487
MAGAASPCANGCGPSAPSDAEVVHLCRSLEVGTVMTLFYSKKSQRPERKTFQVKLETRQITWSRGADKIEGAIDIREIKE
IRPGKTSRDFDRYQEDPAFRPDQSHCFVILYGMEFRLKTLSLQATSEDEVNMWIRGLTWLMEDTLQAATPLQIERWLRKQ
FYSVDRNREDRISAKDLKNMLSQVNYRVPNMRFLRERLTDLEQRTSDITYGQFAQLYRSLMYSAQKTMDLPFLEASALRA
GERPELCRVSLPEFQQFLLEYQGELWAVDRLQVQEFMLSFLRDPLREIEEPYFFLDEFVTFLFSKENSIWNSQLDEVCPD
TMNNPLSHYWISSSHNTYLTGDQFSSESSLEAYARCLRMGCRCIELDCWDGPDGMPVIYHGHTLTTKIKFSDVLHTIKEH
AFVASEYPVILSIEDHCSIAQQRNMAQYFKKVLGDTLLTKPVDIAADGLPSPNQLKRKILIKHKKLAEGSAYEEVPTSVM
YSENDISNSIKNGILYLEDPVNHEWYPHYFVLTSSKIYYSEETSSDQGNEDEEEPKEASGSTELHSNEKWFHGKLGAGRD
GRHIAERLLTEYCIETGAPDGSFLVRESETFVGDYTLSFWRNGKVQHCRIHSRQDAGTPKFFLTDNLVFDSLYDLITHYQ
QVPLRCNEFEMRLSEPVPQTNAHESKEWYHASLTRAQAEHMLMRVPRDGAFLVRKRNEPNSYAISFRAEGKIKHCRVQQE
GQTVMLGNSEFDSLVDLISYYEKHPLYRKMKLRYPINEEALEKIGTAEPDYGALYEGRNPGFYVEANPMPTFKCAVKALF
DYKAQREDELTFTKSAIIQNVEKQEGGWWRGDYGGKKQLWFPSNYVEEMVSPAALEPEREHLDENSPLGDLLRGVLDVPA
CQIAVRPEGKNNRLFVFSISMASVAHWSLDVAADSQEELQDWVKKIREVAQTADARLTEGKMMERRKKIALELSELVVYC
RPVPFDEEKIGTERACYRDMSSFPETKAEKYVNKAKGKKFLQYNRLQLSRIYPKGQRLDSSNYDPLPMWICGSQLVALNF
QTPDKPMQMNQALFLAGGHCGYVLQPSVMRDEAFDPFDKSSLRGLEPCAICIEVLGARHLPKNGRGIVCPFVEIEVAGAE
YDSIKQKTEFVVDNGLNPVWPAKPFHFQISNPEFAFLRFVVYEEDMFSDQNFLAQATFPVKGLKTGYRAVPLKNNYSEGL
ELASLLVKIDVFPAKQENGDLSPFGGASLRERSCDASGPLFHGRAREGSFEARYQQPFEDFRISQEHLADHFDGRDRRTP
RRTRVNGDNRL
PGDR_HUMAN
UNP
2
1
P09619
MRLPGAMPALALKGELLLLSLLLLLEPQISQGLVVTPPGPELVLNVSSTFVLTCSGSAPVVWERMSQEPPQEMAKAQDGT
FSSVLTLTNLTGLDTGEYFCTHNDSRGLETDERKRLYIFVPDPTVGFLPNDAEELFIFLTEITEITIPCRVTDPQLVVTL
HEKKGDVALPVPYDHQRGFSGIFEDRSYICKTTIGDREVDSDAYYVYRLQVSSINVSVNAVQTVVRQGENITLMCIVIGN
EVVNFEWTYPRKESGRLVEPVTDFLLDMPYHIRSILHIPSAELEDSGTYTCNVTESVNDHQDEKAINITVVESGYVRLLG
EVGTLQFAELHRSRTLQVVFEAYPPPTVLWFKDNRTLGDSSAGEIALSTRNVSETRYVSELTLVRVKVAEAGHYTMRAFH
EDAEVQLSFQLQINVPVRVLELSESHPDSGEQTVRCRGRGMPQPNIIWSACRDLKRCPRELPPTLLGNSSEEESQLETNV
TYWEEEQEFEVVSTLRLQHVDRPLSVRCTLRNAVGQDTQEVIVVPHSLPFKVVVISAILALVVLTIISLIILIMLWQKKP
RYEIRWKVIESVSSDGHEYIYVDPMQLPYDSTWELPRDQLVLGRTLGSGAFGQVVEATAHGLSHSQATMKVAVKMLKSTA
RSSEKQALMSELKIMSHLGPHLNVVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQHHSDKRRPPSAELYSNAL
PVGLPLPSHVSLTGESDGGYMDMSKDESVDYVPMLDMKGDVKYADIESSNYMAPYDNYVPSAPERTCRATLINESPVLSY
MDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNSLY
TTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAQPAHASDEIYEIMQKCWEEKFEIRPPFSQLVLLLER
LLGEGYKKKYQQVDEEFLRSDHPAILRSQARLPGFHGLRSPLDTSSVLYTAVQPNEGDNDYIIPLPDPKPEVADEGPLEG
SPSLASSTLNEVNTSSTISCDSPLEPQDEPEPEPQLELQVEPEPELEQLPDSGCPAPRAEAEDSFL
663
759
2PLD
6
102
P08487
A
1
6
102
1018
1029
2PLD
1
12
P09619
B
2
1
12
4
3
parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
A
TRP
11
A
TRP
11
A
HIS
13
A
HIS
13
A
PHE
34
A
PHE
34
A
LYS
38
A
LYS
38
A
TYR
45
A
TYR
45
A
ALA
51
A
ALA
51
A
LYS
54
A
LYS
54
A
VAL
60
A
VAL
60
A
GLN
61
A
GLN
61
A
GLU
63
A
GLU
63
A
THR
66
A
THR
66
A
LEU
69
A
LEU
69
A
SER
72
A
SER
72
A
PHE
74
A
PHE
74
1
P 1